Allogene Therapeutics, Inc.ALLONASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-200.99M
↓ 25% below average
Average (7y)
$-161.16M
Historical baseline
Range
High:$0.00
Low:$-239.25M
Volatility
-148.5%
Relatively stable
PeriodValueChange
2024$-200.99M+16.0%
2023$-239.25M-6.0%
2022$-225.71M-9.4%
2021$-206.26M-13.9%
2020$-181.05M+3.8%
2019$-188.14M-292.9%
2018$-47.89M-
2017$0.00-